Volumen 15 (3) de septiembre 2012 - fasgo

BIBLIOGRAFIA
1. Alijotas-Reig J, Ferrer-Oliveras R. The European
Registry on Obstetric Antiphospholipid Syndrome
(EUROAPS): A preliminary first year report. EU-
ROAPS Study Group. Lupus, June 2012; 21: 766-
768.
2. Wilson WA, Gharavi AE, Koike T, Lockshin MD,
Branch DW, Piette JC, et al. International consensus
statement on preliminary classification criteria
for definite antiphospholipid syndrome: report of an
international workshop. Arthritis Rheum 1999; 42:
1309–11.
3. Miyakis S, Lockshin MD, Atsumi T, Branch DC,
Brey RL, Cervera R, et al. International consensus
statement on an update of the classification criteria
for definite antiphospholipid syndrome (APS). J
Thromb Haemost 2006;4:295–306.
4. Meroni P.L., Raschi E., Testoni C., Borghi M.O.
Endothelial cell activation by antiphospholipid antibodies
(2004) Clinical Immunology, 112 (2), pp. 169-
174.
5. Keeling DM, Campbell SJ, Mackie IJ, Machin SJ,
Isenberg DA. The fibrinolytic response to venous occlusion
and the natural anticoagulants in patients with
antiphospholipid antibodies both with and without
systemic lupus erythematosus. Br J Haematol 1991;
77: 354–9.
6. Reverter JC, Tassies D, Font J, Khamashta MA,
Ichikawa K, Cervera R, et al. Effects of human monoclonal
anticardiolipin antibodies on platelet function
and on tissue factor expression on monocytes. Arthritis
Rheum 1998; 41: 1420–7.
7. Berceanu S, Pătraşcu A, Berceanu C, Tica AA,
Bădulescu A, Brăila MB, Simionescu C. Morphopathological
changes induced by the Obstetrical Antiphospholipid
Antibody Syndrome in fetal adnexa and
uterus. Rom J Morphol Embryol. 2008;49(1):47-52.
8. Branch WD, Silver RM, Blackwell JL, Reading JC,
Scott JR. Outcome of treated pregnancies in women
with antiphospholipid syndrome: an update of the
Utah experience, Obstet Gynecol, 1992, 80(4):614–
620.
9. Backos M, Rai R, Baxter N, Chilcott IT, Cohen H,
Regan L. Pregnancy complications in women with recurrent
miscarriage associated with antiphospholipid
antibodies treated with low dose aspirin and heparin,
Br J Obstet Gynaecol, 1999, 106(2):102–107.
10. Sebire NJ, Backos M, El Gaddal S, Goldin RD,
Regan L. Placental Pathology, Antiphospholipid Antibodies,
and Pregnancy Outcome in Recurrent Miscarriage
158
Patients. Obstet Gynecol 2003; 101: 258–263.
11. Van Horn JT, Craven C, Ward K, Branch DW, Silveremail
RM. Histologic features of placentas and
abortion specimens from women with antiphospholipid
and antiphospholipid-like syndromes. Placenta,
2004, 25(7): 642-648.
12. Gharavi Az, Pierangeli Ss, Levy Ra, Harris En.
Mechanisms of Pregnancy Loss in Antiphospholipid
Syndrome. Clinical Obstetrics & Gynecology, March
2001, 44(1):11-19.
13. Stoneemail S, Pijnenborg R, Vercruysse L, Poston
R, Khamashta MA, Hunt BJ, Poston L. The Placental
Bed in Pregnancies Complicated by Primary Antiphospholipid
Syndrome. Placenta, 2006, 27(4):457-
467
14. Meroni, P. L. et al. Anti-phospholipid antibody
mediated fetal loss: still an open question from a
pathogenic point of view. Lupus, 2010, 19:453–456.
15. Empson M, Lassere M, Craig J, Scott J. Prevention
of recurrent miscarriage for women with antiphospholipid
antibody or lupus anticoagulant. Cochrane
Database Syst Rev. 2005; 18(2):1-63.
16. Rand JH, Wu XX. Antibody-mediated disruption
of the annexin-V antithrombotic shield: a new mechanism
for thrombosis in the antiphospolipid syndrome.
Thromb Haemost 1999;82:649-655.
17. Rand JH, Wu XX, Andree HAM, M.D., Lockwood
CJ, Guller S, Scher J, Harpel PC. Pregnancy
Loss in the Antiphospholipid-Antibody Syndrome —
A Possible Thrombogenic Mechanism. N Engl J Med
1997; 337:154-160.
18. Branch DW, Andres R, Digre KB, Rote NS, Scott
JR. The Association of Antiphospolipid Antibodies
with Severe Preeclampsia. Obstet & Gynecol 1989;
73(4): 541-545.
19. van Pampus MG, Dekker GA, Wolf H, Huijgens
PC, Koopman MMW, von Blomberg BM, Büller RH.
High prevalence of hemostatic abnormalities in women
with a history of severe preeclampsia. American
Journal of Obstetrics & Gynecology, May 1999;
180(5):1146-1150.
20. Dekker GA, de Vries JIP, Doelitzsch PM, Huijgens
PC, von Blomberg BME, Jakobs C, van Geijn
HP. Underlying disorders associated with severe
early-onset preeclampsia. American Journal of Obstetrics
& Gynecology, October 1995; 173(4):1042-
1048.
21. Ferrer-Oliveras R, Llurba E, Cabero-Roura L,
Alijotas-Reig J. Prevalence and clinical usefulness
of the antiphospholipid and anti-cofactor antibodies
in different Spanish preeclampsia subsets. Lupus,
Rev. Latin. Perinat. 15 (3) 2012